Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| NOVARTIS PHARMACEUTICALS UK LIMITED | 00119006 | - | 1 lot Lot 1 | DONOR£3K across 2 donations To: Mr Nicholas Palmer LOBBYIST M&F Health (7 quarters) Sovereign Strategy Limited (1 quarter) MP LINK Mr David Lammy— Employment and earnings |
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £1,532,304 initial term | 1 single bid — no competition | active |
Weightings from the notice.
Government spending data: This supplier has received £169,787,630 in 1,452 payments (over £25k) from Manchester University NHS Foundation Trust, NHS England, Guy's and St Thomas' NHS FT, Maidstone and Tunbridge Wells NHS Trust, East Sussex Healthcare NHS Trust and 9 more public bodies (2018-04-10 to 2026-03-23). View full payment history →